Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / PFE - Novavax Sizzles On 89% Efficacy For COVID-19 Vaccine Still A Hold

PFE - Novavax Sizzles On 89% Efficacy For COVID-19 Vaccine Still A Hold

Pfizer Inc.
  • The moment of truth arrived. NVAX reported 89% efficacy for its COVID-19 vaccine. The stock shot up over 60% on the news.
  • I expect Emergency Use Authorization soon. NVAX's supply chain could allow it to take market share from competitors.
  • NVAX trades at 3.7x expected 2021 COVID-19 revenue, which I believe is warranted. NVAX remains a hold.

For further details see:

Novavax Sizzles On 89% Efficacy For COVID-19 Vaccine, Still A Hold
Stock Information
Company Name: Pfizer Inc.
Stock Symbol: PFE
Market: NYSE
Website: pfizer.com
Menu
PFE PFE Quote PFE Short PFE News PFE Articles PFE Message Board
Get PFE Alerts

News, Short Squeeze, Breakout and More Instantly...